Royal Bank Of Canada Common Stock (RY)

Long-Term Debt

$404.77B

Quarterly · Period ending: · CAD

RY logo

RY Long-Term Debt

Latest reported$404.77B CAD
RY Quarterly Long-Term Debt · CAD ($3.46B → $404.77B)
High-resolution chart · PNG

RY long-term debt history

Quarterly · CAD. Dates are reporting period ends; fiscal years can differ from calendar years.

Royal Bank Of Canada Common Stock Long-Term Debt — Quarterly (CAD)
Period endingLong-Term Debt (CAD)
404,774,408,000
376,732,321,000
84,729,268,000
358,395,000,000
348,888,000,000
351,882,000,000
344,337,000,000
338,185,000,000
321,720,000,000
322,992,000,000
317,106,000,000
321,030,000,000
321,007,000,000
336,406,000,000
305,098,000,000
282,224,000,000
249,348,000,000
236,383,000,000
215,880,000,000
205,549,000,000
183,748,000,000
173,280,000,000
186,556,000,000
186,632,000,000
185,582,000,000
189,646,000,000
189,707,000,000
172,238,000,000
169,216,000,000
163,212,000,000
165,977,000,000
163,310,000,000
9,129,000,000
9,068,000,000
8,961,000,000
151,316,000,000
9,200,000,000
9,646,000,000
9,487,000,000
158,419,000,000
9,765,000,000
9,564,000,000
9,854,000,000
155,958,000,000
7,374,000,000
7,795,000,000
7,889,000,000
133,491,000,000
6,810,000,000
6,486,000,000
6,521,000,000
7,443,000,000
7,392,000,000
8,503,000,000
9,441,000,000
7,615,000,000
7,646,000,000
7,553,000,000
8,744,000,000
8,749,000,000
7,617,000,000
7,603,000,000
8,041,000,000
6,681,000,000
6,661,000,000
5,813,000,000
5,896,000,000
6,461,000,000
6,486,000,000
7,629,000,000
7,783,923,000
8,131,313,000
7,925,281,000
8,349,407,000
7,265,060,000
6,234,982,000
6,203,812,000
8,187,465,000
8,191,652,000
8,486,480,000
7,822,152,000
9,228,536,000
9,515,248,000
9,566,655,000
10,231,419,000
8,100,756,000
8,190,275,000
10,415,752,000
8,440,452,000
8,423,145,000
7,638,962,000
6,242,912,000
2,354,348,000
6,474,295,000
6,570,864,000
6,613,707,000
7,043,547,000
7,025,247,000
7,104,388,000
6,313,284,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.